Advance Care Planning for Cancer
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Facilitated advance care planning (in-person or telephonic), Web-based advance care planning for cancer?
Research shows that web-based advance care planning programs can help patients think about and discuss their future treatment preferences, and online programs like PREPARE have been effective in engaging patients in planning their care. Additionally, good communication, such as through a Values Assessment, is linked to better outcomes at the end of life.12345
Is advance care planning safe for cancer patients?
Advance care planning, whether facilitated in-person, telephonically, or through web-based resources, has been found to be feasible and acceptable for patients with advanced illnesses, including cancer. Patients and caregivers have reported high satisfaction with the process, and no significant safety concerns have been noted in the studies reviewed.678910
How is the treatment 'Facilitated advance care planning' unique for cancer patients?
Facilitated advance care planning (ACP) is unique because it involves personalized discussions, either in-person or over the phone, to help patients and their families understand and express their preferences for future care. This approach can improve family involvement in decision-making and reduce stress, making it different from standard treatments that may not focus on these aspects.27111213
What is the purpose of this trial?
The overall goal of this study is to identify the most effective and efficient advance care planning (ACP) strategy for patients with advanced cancer.The specific aims are to:Aim 1. Compare the effectiveness of in-person, facilitated ACP versus web-based ACP on patient and family caregiver outcomes.Aim 2. Assess implementation costs and the effects of in-person, facilitated ACP and web-based ACP on healthcare utilization at end of life.Aim 3. Identify contexts and mechanisms that influence the effectiveness of in-person, facilitated ACP versus web-based ACP.
Research Team
Yael Schenker, MD, MAS
Principal Investigator
University of Pittsburgh
Eligibility Criteria
This trial is for adults with advanced cancer who are expected to continue care at a participating clinic, can participate in either web-based or facilitated advance care planning (ACP), and have someone involved in their care. Excluded are those without phone access, unable to consent, with blood cancers, or unable to complete the baseline interview.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either in-person facilitated ACP discussions or web-based ACP using interactive videos
Follow-up
Participants are monitored for outcomes such as ACP engagement and healthcare utilization until 12 weeks after the patient's death or completion of the 48-month data collection period
Treatment Details
Interventions
- Facilitated advance care planning (in-person or telephonic)
- Web-based advance care planning
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pittsburgh
Lead Sponsor
National Cancer Institute (NCI)
Collaborator